Infectious Diseases News and Research

RSS

Exuberant activation of immune cells in severe COVID-19 resembles lupus

In severe cases of COVID-19, Emory researchers have been observing an exuberant activation of immune cells, resembling acute flares of systemic lupus erythematosus (SLE), an autoimmune disease.

9 Oct 2020

Transplantation of pig hearts may solve chronic shortage of donor organs

The goal of harvesting hearts from pigs to solve the chronic shortage of these donor organs appears to be in reach, according to a new scientific review by researchers at Massachusetts General Hospital (MGH).

9 Oct 2020

Scientists recreate initial steps of HIV infection in a test tube

Accomplishing a feat that had been a pipe dream for decades, scientists have recreated in a test tube the first steps of infection by HIV (human immunodeficiency virus), the virus that causes AIDS (acquired immunodeficiency syndrome).

9 Oct 2020

University of Minnesota Medical School chosen as ‘Capacity Building Center’ for national network

The University of Minnesota Medical School's Department of Laboratory Medicine and Pathology has been selected to participate in a new national network dedicated to serological, or antibody, sciences as one of four Capacity Building Centers in the country.

9 Oct 2020

Mount Sinai to receive more than $7.3 million as part of NCI's new Serological Sciences Network

Researchers from the Icahn School of Medicine at Mount Sinai will receive more than $7.3 million from the National Cancer Institute as part of the NCI's new Serological Sciences Network (SeroNet), one of the largest coordinated national efforts to study immunology and SARS-CoV-2, the virus that causes COVID-19.

8 Oct 2020

NIH clinical trial to test a combination treatment regimen for COVID-19

A clinical trial to test the safety, tolerability and efficacy of a combination treatment regimen for coronavirus disease 2019 (COVID-19) consisting of the antiviral remdesivir plus a highly concentrated solution of antibodies that neutralize SARS-CoV-2, the virus that causes COVID-19, has begun.

8 Oct 2020

SARS-CoV-2 survives on human skin for 9 hours

Japanese researchers have now studied the survival possibilities of the flu virus and the SARS-CoV-2 on human skin. Their study titled, "Survival of SARS-CoV-2 and influenza virus on the human skin: Importance of hand hygiene in COVID-19," was published in the latest issue of the journal Clinical Infectious Diseases.

8 Oct 2020

In debate, Pence and Harris offer conflicting views of nation’s reality

The Trump administration's pandemic response: decisive action that saved lives, or the greatest failure of any presidential administration? During Wednesday's vice presidential debate, Vice President Mike Pence and the Democratic challenger, Sen. Kamala Harris of California, offered drastically different takes — from behind plexiglass screens — on how the president has handled the COVID-19 crisis.

8 Oct 2020

The Native Antigen Company introduces ten new SARS-CoV-2 specific antibodies

The Native Antigen Company, one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the introduction of ten new monoclonal antibodies recognizing SARS-CoV-2, the causative agent of COVID-19.

8 Oct 2020

Researchers track down two new relatives of rubella virus

At night in a Ugandan forest, a team of American and African scientists take oral swabs from insect-eating cyclops leaf-nosed bats.

8 Oct 2020

Comet supercomputer performs complex calculations on receptor sequence data from human T cells

While researchers around the world race to develop an effective and safe COVID-19 vaccine, a team from the San Diego Supercomputer Center (SDSC) at UC San Diego contributed to a study led by Vanderbilt Vaccine Center of Vanderbilt University Medical Center (VUMC) on T cell receptors, which play a vital role in alerting the adaptive immune system to mount an attack on invading foreign pathogens including the Coronavirus SARS-CoV-2.

8 Oct 2020

People infected with other types of coronaviruses may have less severe COVID-19 infection

Being previously infected with a coronaviruses that cause the "common cold" may decrease the severity of severe acute respiratory syndrome coronavirus (SARS-CoV-2) infections, according to results of a new study

7 Oct 2020

Many hospitalized COVID-19 patients exhibit neurological symptoms, study finds

Nearly a third of hospitalized COVID-19 patients experienced some type of altered mental state and function, ranging from delirium to confusion, and in some cases, unresponsiveness, a new study has found.

7 Oct 2020

Dried blood spot samples accurately detect anti-SARS-CoV-2 S glycoprotein antibodies

Using dried blood spot samples (DBS) is an accurate alternative to venous blood in detecting SARS-CoV-2 antibody tests, a new study by immunology experts at the University of Birmingham has found.

6 Oct 2020

Analysis: ‘Don’t be afraid of COVID’? Not buying it, unless businesses do job right

As stores, restaurants, airlines and offices try to lure clients back, this is what they need to do to earn my business: Make me feel safe — no, make me be as safe as possible. As I've begun to explore old haunts, some are doing a fabulous job. Others are not.

6 Oct 2020

Easier-to-use coronavirus saliva tests start to catch on

As the coronavirus pandemic broke out across the country, health care providers and scientists relied on the standard method for detecting respiratory viruses: sticking a long swab deep into the nose to get a sample. The obstacles to implementing such testing on a mass scale quickly became clear.

6 Oct 2020

Antibiotics might be a feasible treatment option for appendicitis, shows study

Henry Ford Health System surgeons involved in the study say patients should choose the best option in consultation with their physician.

6 Oct 2020

SARS-CoV-2 and anti-COVID-19 drugs activate Kaposi sarcoma-associated herpesvirus

A new study published on the preprint server bioRxiv* aimed to investigate the impacts of COVID-19 on people with various illnesses. Specifically, the researchers at the Rockefeller Cancer Institute, and the University of Arkansas for Medical Sciences wanted to see the effects of COVID-19 on patients with cancer and other infectious diseases.

6 Oct 2020

CODA trial shows antibiotics may be a good choice for certain patients with appendicitis

Antibiotics may be a good choice for some, but not all, patients with appendicitis, according to results from the Comparing Outcomes of antibiotic Drugs and Appendectomy (CODA) Trial reported today in the New England Journal of Medicine.

6 Oct 2020

Study shows why antiretroviral therapy does not work in certain HIV patients

Increasingly, UPMC's chief of infectious diseases - a well-regarded expert in HIV/AIDS - is contacted by a perplexed physician describing a patient with HIV who insists they are adhering to the daily medication regimen meant to keep the virus in check, but testing says otherwise.

6 Oct 2020

Infectious Diseases News and Research

Exuberant activation of immune cells in severe COVID-19 resembles lupus

Transplantation of pig hearts may solve chronic shortage of donor organs

Scientists recreate initial steps of HIV infection in a test tube

University of Minnesota Medical School chosen as ‘Capacity Building Center’ for national network

Mount Sinai to receive more than $7.3 million as part of NCI's new Serological Sciences Network

NIH clinical trial to test a combination treatment regimen for COVID-19

SARS-CoV-2 survives on human skin for 9 hours

In debate, Pence and Harris offer conflicting views of nation’s reality

The Native Antigen Company introduces ten new SARS-CoV-2 specific antibodies

Researchers track down two new relatives of rubella virus

Comet supercomputer performs complex calculations on receptor sequence data from human T cells

People infected with other types of coronaviruses may have less severe COVID-19 infection

Many hospitalized COVID-19 patients exhibit neurological symptoms, study finds

Dried blood spot samples accurately detect anti-SARS-CoV-2 S glycoprotein antibodies

Analysis: ‘Don’t be afraid of COVID’? Not buying it, unless businesses do job right

Easier-to-use coronavirus saliva tests start to catch on

Antibiotics might be a feasible treatment option for appendicitis, shows study

SARS-CoV-2 and anti-COVID-19 drugs activate Kaposi sarcoma-associated herpesvirus

CODA trial shows antibiotics may be a good choice for certain patients with appendicitis

Study shows why antiretroviral therapy does not work in certain HIV patients

Industry Focus: Infectious Diseases eBook

The Critical Role of Sample Storage in Drug Discovery and Development

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

Latest News